NEWS
Biotech slams ‘nonsense information’ about company prospects
MELBOURNE: The chair of billion-dollar biotech Clinuvel has used the company’s annual general meeting to… read more
Alzheimer’s drug aducanumab faces major setback over approval
WASHINGTON D.C.: For almost two decades, the field of Alzheimer’s research has been dogged by… read more
Charity sector in line for NSW budget $50m
SYDNEY: Social housing tenants will be encouraged to apply for traineeships on social housing construction… read more
Medigard collapses into administration as COVID hits
BRISBANE: A Queensland ASX-listed company specialising in the development of medical technology has been tipped… read more
